Tela Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Tela Bio
TELA Stock  USD 1.47  0.13  8.13%   
Tela Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tela Bio's valuation are provided below:
Gross Profit
48 M
Profit Margin
(0.61)
Market Capitalization
63.3 M
Enterprise Value Revenue
0.9798
Revenue
71.2 M
We have found one hundred twenty available fundamental trend indicators for Tela Bio, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Tela Bio current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 107.2 M. The current year's Enterprise Value is expected to grow to about 97.8 M

Tela Bio Total Revenue

72.77 Million

Check Tela Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tela Bio's main balance sheet or income statement drivers, such as Interest Income of 2.6 M, Depreciation And Amortization of 915.5 K or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0 or PTB Ratio of 4.06. Tela financial statements analysis is a perfect complement when working with Tela Bio Valuation or Volatility modules.
  
Build AI portfolio with Tela Stock
Check out the analysis of Tela Bio Correlation against competitors.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

Tela Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets67.7 M86.6 M41.8 M
Slightly volatile
Short and Long Term Debt Total34.6 M41.7 M20.6 M
Slightly volatile
Other Current Liabilities9.4 M16.9 M5.8 M
Slightly volatile
Total Current Liabilities11.6 M15.6 M8.7 M
Slightly volatile
Other Liabilities324.9 K342 K1.5 M
Slightly volatile
Property Plant And Equipment Net2.1 M4.1 M1.6 M
Slightly volatile
Current Deferred Revenue1.3 M1.4 M1.6 M
Slightly volatile
Accounts Payable1.7 M2.1 M1.8 M
Pretty Stable
Cash45.9 M52.7 M28.7 M
Slightly volatile
Non Current Assets Total4.9 M8.5 M3.1 M
Slightly volatile
Other Assets19.2 K21.6 K23.6 K
Slightly volatile
Long Term Debt34 M41.1 M19.2 M
Slightly volatile
Cash And Short Term Investments47.2 M52.7 M29.3 M
Slightly volatile
Net Receivables5.3 M10.1 M3.1 M
Slightly volatile
Common Stock Shares Outstanding16.4 M28.5 M11.3 M
Slightly volatile
Long Term Debt Total30.4 M45.9 M20.2 M
Slightly volatile
Liabilities And Stockholders Equity67.7 M86.6 M41.8 M
Slightly volatile
Non Current Liabilities Total49.2 M42.5 M85.2 M
Slightly volatile
Inventory8.3 M12.8 M5.1 M
Slightly volatile
Other Current Assets3.2 M2.5 M1.8 M
Slightly volatile
Other Stockholder Equity235.9 M387.1 M123.2 M
Slightly volatile
Total Liabilities57.6 M58.1 M93.8 M
Slightly volatile
Property Plant And Equipment Gross9.2 M8.7 M2.8 M
Slightly volatile
Short and Long Term Debt724 K814.5 K888 K
Slightly volatile
Total Current Assets62.8 M78.1 M38.7 M
Slightly volatile
Non Current Liabilities Other879.1 K1.4 M821.6 K
Pretty Stable
Net Working Capital51.1 M62.5 M30 M
Slightly volatile
Short Term Debt471 K545 K657.6 K
Slightly volatile
Common Stock41 K39 K14.1 K
Slightly volatile
Property Plant Equipment1.1 M1.9 M1.2 M
Slightly volatile
Intangible Assets2 M1.7 M2.8 M
Slightly volatile
Common Stock Total Equity16.2 K21.9 K13.4 K
Slightly volatile
Capital Surpluse270.3 M331.6 M229.2 M
Slightly volatile

Tela Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income2.6 M3.3 M3.8 M
Slightly volatile
Depreciation And Amortization915.5 K1 M806.3 K
Pretty Stable
Interest Expense4.4 M5.3 M4.2 M
Very volatile
Selling General Administrative11.3 M14.7 M8 M
Slightly volatile
Selling And Marketing Expenses35.6 M64.6 M22.2 M
Slightly volatile
Total Revenue72.8 M69.3 M21.7 M
Slightly volatile
Gross Profit48.8 M46.5 M14.1 M
Slightly volatile
Other Operating Expenses66 M111 M43.4 M
Slightly volatile
Research Development7.2 M8.8 M6.3 M
Slightly volatile
Cost Of Revenue11.9 M22.8 M6.9 M
Slightly volatile
Total Operating Expenses53.1 M80.6 M36 M
Slightly volatile
Reconciled Depreciation921.8 K1 M809.5 K
Pretty Stable

Tela Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings9.8 M5.9 M11.3 M
Slightly volatile
Stock Based Compensation2.7 M4.4 M1.5 M
Slightly volatile
Begin Period Cash Flow38.9 M47 M20.7 M
Slightly volatile
Depreciation915.5 K1 M806.3 K
Pretty Stable
Other Non Cash Items2 M1.3 M3.1 M
Slightly volatile
Capital Expenditures863.9 K989 K643.8 K
Slightly volatile
Total Cash From Financing Activities40.5 M43.1 M32.5 M
Slightly volatile
End Period Cash Flow46 M52.9 M28.7 M
Slightly volatile
Change To Netincome5.1 M8 M4.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.181.243113.1099
Slightly volatile
Days Sales Outstanding64.3453.185761.7431
Slightly volatile
Stock Based Compensation To Revenue0.05850.06290.0605
Slightly volatile
Capex To Depreciation1.490.97730.8359
Slightly volatile
EV To Sales1.031.084412.1345
Slightly volatile
Inventory Turnover1.111.78481.1751
Slightly volatile
Days Of Inventory On Hand301205325
Slightly volatile
Payables Turnover11.1610.62514.367
Slightly volatile
Sales General And Administrative To Revenue0.20.21240.77
Slightly volatile
Research And Ddevelopement To Revenue0.120.12720.7992
Slightly volatile
Capex To Revenue0.01360.01430.0433
Very volatile
Cash Per Share3.371.84642.5043
Slightly volatile
Days Payables Outstanding32.6434.3528203
Slightly volatile
Income Quality0.751.09920.8518
Slightly volatile
Intangibles To Total Assets0.01910.02010.0797
Slightly volatile
Current Ratio4.685.00524.2386
Slightly volatile
Receivables Turnover5.036.86275.9113
Slightly volatile
Capex Per Share0.03290.03470.0552
Pretty Stable
Revenue Per Share1.422.42931.2662
Slightly volatile
Interest Debt Per Share2.851.64622.084
Slightly volatile
Debt To Assets0.590.48130.4321
Slightly volatile
Operating Cycle365258387
Slightly volatile
Days Of Payables Outstanding32.6434.3528203
Slightly volatile
Ebt Per Ebit1.261.11341.2049
Slightly volatile
Quick Ratio4.154.18583.7452
Slightly volatile
Net Income Per E B T1.11.151.0161
Slightly volatile
Cash Ratio4.863.37673.3197
Slightly volatile
Cash Conversion Cycle169223173
Slightly volatile
Days Of Inventory Outstanding301205325
Slightly volatile
Days Of Sales Outstanding64.3453.185761.7431
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.141.02381.0307
Slightly volatile
Fixed Asset Turnover13.7416.989511.0456
Slightly volatile
Debt Ratio0.590.48130.4321
Slightly volatile
Price Sales Ratio1.181.243113.1099
Slightly volatile
Asset Turnover0.840.80050.4
Slightly volatile
Gross Profit Margin0.480.67080.5921
Very volatile

Tela Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap107.2 M86.1 M112.7 M
Slightly volatile
Enterprise Value97.8 M75.1 M103.6 M
Slightly volatile

Tela Fundamental Market Drivers

Cash And Short Term Investments52.7 M

Tela Upcoming Events

19th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Tela Bio Financial Statements

Tela Bio stakeholders use historical fundamental indicators, such as Tela Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tela Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tela Bio's assets and liabilities are reflected in the revenues and expenses on Tela Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tela Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.3 M
Total Revenue69.3 M72.8 M
Cost Of Revenue22.8 M11.9 M
Stock Based Compensation To Revenue 0.06  0.06 
Sales General And Administrative To Revenue 0.21  0.20 
Research And Ddevelopement To Revenue 0.13  0.12 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.43  1.42 
Ebit Per Revenue(0.49)(0.52)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
CCitigroup
VVisa Class A
When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:
How To Invest In Tela
Details
Is Tela Stock a good investment?
Details
What is Tela Bio's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Tela Bio Correlation against competitors.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.06)
Revenue Per Share
2.113
Quarterly Revenue Growth
0.115
Return On Assets
(0.33)
Return On Equity
(2.67)
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY